LVRT Levrett

TIDMNFX

Nuformix PLC

11 March 2021

REACH: non-regulatory announcement

Nuformix plc

("Nuformix", the "Company" or the "Group")

Initiation of research by Allenby Capital

Cambridge, UK - 11 March 2021: Nuformix plc (LSE:NFX), a pharmaceutical development company and drug re-purposing specialist, is pleased to announce the initiation of research by Allenby Capital Limited, the Company's broker.

The research is available on the Allenby Capital website here:

Allenby Capital

Enquiries:

 
 Nuformix plc 
  Dr Anne Brindley, CEO 
  Fleur Wood, Investor Relations                        +44 (0)1223 627222 
 
   Allenby Capital Limited 
   Tim Sohal / Matt Butlin (Sales and Corporate 
   Broking) 
   Nick Athanas / George Payne (Corporate Finance)      +44 (0)203 328 5656 
 

About Nuformix

Nuformix is a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing. The Company aims to use its expertise in discovering, developing and patenting novel drug forms, with improved physical properties, to develop new products in new indications that are, importantly, differentiated from the original (by way of dosage, delivery route or presentation), thus creating new and attractive commercial opportunities.

For more information, please visit www.nuformix.com .

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted companies to distribute media only / non-regulatory news releases into the public domain.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word "Reach" in the source column of the News Explorer pages of London Stock Exchange's website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAFFFFIVFIILIL

(END) Dow Jones Newswires

March 11, 2021 02:00 ET (07:00 GMT)

Levrett (LSE:LVRT)
Historical Stock Chart
From Apr 2024 to May 2024

Levrett (LSE:LVRT)
Historical Stock Chart
From May 2023 to May 2024